Why does activated partial thromboplastin time prolongation occur in severe fever with thrombocytopenia syndrome?

被引:5
|
作者
Mizoe, Atsushi [1 ]
Sakaue, Junya [2 ]
Takahara, Noriko [1 ]
机构
[1] Ako City Hosp, Dept Internal Med, Ako, Hyogo, Japan
[2] Kyoto Univ Hosp, Integrated Clin Educ Ctr, Kyoto, Japan
关键词
infectious diseases; haematology (incl blood transfusion); VIRUS; TICK;
D O I
10.1136/bcr-2020-235447
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe fever with thrombocytopenia syndrome (SFTS) is caused by infection with SFTS virus and this mortality rate is 16.2% to 30%. An 85-year-old male patient presented to the emergency department of the hospital with primary complaints of fever and consciousness disturbance. Haemophagocytic syndrome and prolonged activated partial thromboplastin time (APTT) without associated prolonged prothrombin time were observed, suggesting SFTS, which was eventually diagnosed. APTT-only prolongation has been reported previously with SFTS, but the mechanism is unknown. The absence of coagulation factors was determined by a cross-mixing study. In addition, examination of intrinsic coagulation factors showed reduced factor XI activity. These results suggest that factor XI is causally related to APTT-only prolongation in SFTS.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies
    Tsukamoto, Yutaka
    Sugimoto, Takashi
    Umeda, Masataka
    Kato, Takeharu
    Hiura, Yukari
    Morita, Kouichi
    Ariyoshi, Koya
    INTERNAL MEDICINE, 2023, 62 (14) : 2145 - 2149
  • [2] Activated partial thromboplastin time predicts mortality in patients with severe fever with thrombocytopenia syndrome: A multicenter study in north China
    Peng, Wenjuan
    Li, Junnan
    Yu, Hong
    Zhou, Wei
    Lin, Ling
    Ge, Ziruo
    Lai, Jianming
    Chen, Zhihai
    Zhu, Liuluan
    Zhao, Zhenghua
    Shen, Yi
    Jin, Ronghua
    Duan, Jianping
    Zhang, Wei
    HELIYON, 2024, 10 (11)
  • [3] SPURIOUS PROLONGATION OF ACTIVATED PARTIAL THROMBOPLASTIN TIME
    OKPARA, RA
    CARABELLO, JA
    DAY, HJ
    THROMBOSIS AND HAEMOSTASIS, 1977, 38 (04) : 900 - 908
  • [4] Activated partial thromboplastin time and Q fever
    Sánchez, JF
    Pérez, S
    Ojeda, I
    Ortiz, C
    MEDICINA CLINICA, 1999, 113 (16): : 639 - 639
  • [5] KAOLIN-CORRECTABLE PROLONGATION OF THE ACTIVATED PARTIAL THROMBOPLASTIN TIME
    BRISELLI, MF
    ELLMAN, L
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1980, 74 (05) : 677 - 680
  • [7] Challenge and rechallenge: Drotrecogin alfa (activated)-induced prolongation of activated partial thromboplastin time in a patient with severe sepsis
    Castelli, EE
    Culley, CM
    Fink, MR
    PHARMACOTHERAPY, 2005, 25 (08): : 1147 - 1150
  • [8] Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
    Santoro, Rita Carlotta
    Molinari, Angelo Claudio
    Leotta, Marzia
    Martini, Tiziano
    MEDICINA-LITHUANIA, 2023, 59 (06):
  • [9] ARTIFACTUAL PROLONGATION OF THE ACTIVATED PARTIAL THROMBOPLASTIN TIME ASSOCIATED WITH HEMOCONCENTRATION IN DOGS
    OBRIEN, SR
    SELLERS, TS
    MEYER, DJ
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 1995, 9 (03) : 169 - 170
  • [10] Thrombolytic fibrin specificity influences activated partial thromboplastin time prolongation
    Tsikouris, JP
    Jackson, KC
    Cox, CD
    Meyerrose, GE
    Diaz, JA
    Seifert, CF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 331A - 332A